Judith A Varner

This inventor holds 11 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: University of California, Ixsys, Incorporated. Active years: 1998-2023.

USPTO Granted Patents = 11 (Patent Applications = 3)

% Patents Active = 63.6

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 1.4

ph-index = 5

Forward Citations = 178(Granted Patents)

Location History:

Encinitas, CA (US) (1998 - 2016)
La Jolla, CA (US) (2022 - 2023)

Company Filing History:

9 out of 15,964

University of California

Years Active: 1998-2023

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11679100 - Methods of enhancing immunity (2023-06-20),

2. 11344559 - PI3KGAMMA inhibitors (2022-05-31),

3. 9403908 - Method for altering hematopoietic progenitor cell adhesion, differentiation, and migration (2016-08-02),

4. 8808698 - Methods for inhibition of lymphangiogenesis and tumor metastasis (2014-08-19),

5. 8454958 - Methods for detecting and inhibiting angiogenesis (2013-06-04),

6. 7824680 - Methods for inhibiting angiogenesis (2010-11-02),

7. 7311911 - Methods for inhibiting angiogenesis (2007-12-25),

8. 7056506 - Methods for detecting and inhibiting angiogenesis (2006-06-06),

9. 6852318 - Methods for detecting and inhibiting angiogenesis (2005-02-08),

10. 5780426 - Fivemer cyclic peptide inhibitors of diseases involving .alpha..sub.v (1998-07-14),

11. 5767071 - Sevenmer cyclic peptide inhibitors of diseases involving .alpha..sub.v (1998-06-16),

Title: Judith A Varner: Innovator in Cancer Immunotherapy

Introduction

Judith A Varner is a prominent inventor based in Encinitas, CA (US). She has made significant contributions to the field of cancer immunotherapy, holding a total of 11 patents. Her work focuses on enhancing immune responses to combat cancer effectively.

Latest Patents

Among her latest patents, one notable invention is related to methods of enhancing immunity. This invention is based on the finding that CD11b signaling inhibits immune suppression, modulates neovascularization, and promotes anti-tumor immune responses in both murine and human cancer models. The methods provided include treating cancer using an antibody, protein, or small molecule that modulates CD11b activity or expression. Additionally, she has developed methods for identifying cancers that are amenable to such treatment and increasing the susceptibility of cancer cells to chemotherapeutic agents. Another significant patent involves PI3Kγ inhibitors, which relates to the use of these inhibitors and their methods.

Career Highlights

Judith has worked with esteemed institutions such as the University of California and Ixsys, Incorporated. Her research has been pivotal in advancing the understanding of immune mechanisms in cancer treatment.

Collaborations

Throughout her career, Judith has collaborated with notable colleagues, including Bruce Andrew Lee and William D Huse. These collaborations have further enriched her research and contributions to the field.

Conclusion

Judith A Varner's innovative work in cancer immunotherapy exemplifies her dedication to enhancing treatment options for patients. Her numerous patents reflect her significant impact on the scientific community and the ongoing fight against cancer.